Medicure Inc.
MCUJF
$0.80
-$0.04-4.24%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 44.92% | 29.43% | 21.11% | 7.61% | -3.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.92% | 29.43% | 21.11% | 7.61% | -3.45% |
| Cost of Revenue | 102.12% | 90.65% | 40.33% | 21.06% | 14.46% |
| Gross Profit | 1.34% | -11.88% | 5.80% | -1.31% | -13.73% |
| SG&A Expenses | 25.13% | 19.30% | -2.04% | -2.86% | -4.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.13% | 42.60% | 12.57% | 5.95% | 3.98% |
| Operating Income | -109.12% | -147.50% | 31.31% | 6.27% | -118.94% |
| Income Before Tax | -341.66% | -778.72% | -59.04% | 57.09% | -33.02% |
| Income Tax Expenses | -31.60% | -19.53% | 187.07% | 120.85% | 413.32% |
| Earnings from Continuing Operations | -286.12% | -580.88% | -65.03% | 50.79% | -49.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -286.12% | -580.88% | -65.03% | 50.79% | -49.50% |
| EBIT | -109.12% | -147.50% | 31.31% | 6.27% | -118.94% |
| EBITDA | -255.98% | -383.17% | 53.92% | 18.00% | -530.16% |
| EPS Basic | -286.18% | -580.47% | -65.06% | 50.81% | -49.39% |
| Normalized Basic EPS | -113.45% | -156.55% | 30.93% | 4.85% | -120.29% |
| EPS Diluted | -274.25% | -565.50% | -66.28% | 48.32% | -49.82% |
| Normalized Diluted EPS | -113.76% | -156.38% | 31.04% | 5.24% | -118.54% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.14% | 0.00% | 0.00% | -2.98% | -3.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |